Phase III trial of epoetin alfa in patients with anaemia due to chronic renal failure

Next Previous
Trial Profile

Phase III trial of epoetin alfa in patients with anaemia due to chronic renal failure

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs Erythropoietin (Primary)
  • Indications Anaemia
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 09 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top